Concepedia

Vicente Alfaro

VA

Statistics

Publications

51

Citations

2.2K

H-Index

24

Active since

1992

Affiliations

PharmaMar (Spain)(Current)

Universitat de Barcelona

Institut Gustave Roussy

Hospital Universitario 12 De Octubre

Institut d'Investigacions Biomèdiques de Barcelona

Vicente Alfaro is an author at PharmaMar (Spain) specializing in pharmacology, medicine, and oncology.

ORCID

Publications per year

1992–2023

51

Publications

51

Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial

José Trigo, Vivek Subbiah, Benjamin Besse et al. · The Lancet Oncology · 2020 · 462 citations

, , +9

Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer: outcomes in the partially platinum-sensitive (platinum-free interval 6–12 months) subpopulation of OVA-301 phase III randomized trial

Andrés Poveda, Ignace Vergote, Sergei Tjulandin et al. · Annals of Oncology · 2010 · 168 citations · Full text

, , +15

Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma

Alessandro Gronchi, B. Bui, Sylvie Bonvalot et al. · Annals of Oncology · 2011 · 146 citations · Full text

, , +17

A retrospective analysis of antitumour activity with trabectedin in translocation-related sarcomas

Axel Le Cesne, Sara Cresta, Robert G. Maki et al. · European Journal of Cancer · 2012 · 141 citations · Full text

, , +13

Randomised phase III trial of trabectedin versus doxorubicin-based chemotherapy as first-line therapy in translocation-related sarcomas

Jean‐Yves Blay, Michael Leahy, Binh Bui Nguyen et al. · European Journal of Cancer · 2014 · 120 citations · Full text

, , +12

1–5 of 51